InvestSMART

Pharmaxis Ltd (ASX: PXS) - Announcements

- Current share price for PXS : $0.027

ASX company news and announcements for Pharmaxis Ltd (PXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Pharmaxis Ltd (PXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Pharmaxis Ltd (PXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Pharmaxis Ltd (PXS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Appendix 2A - Exercise of Employee Options 6 Apr 2020 2:41PM $0.100 $0.027 fallen by 73%
- Appendix 2A - Exercise of Employee Options 12 Mar 2020 9:15AM $0.083 $0.027 fallen by 67.47%
- Half Yearly Report and Accounts 13 Feb 2020 3:39PM $0.110 $0.027 fallen by 75.45%
- Appendix 2A 13 Feb 2020 3:35PM $0.110 $0.027 fallen by 75.45%
- Appendix 3G - Exercise of Employee Options 12 Feb 2020 3:02PM $0.110 $0.027 fallen by 75.45%
- Appendix 4C - quarterly 31 Jan 2020 8:34AM $0.115 $0.027 fallen by 76.52%
- Quarterly Shareholder Update - December 2019 31 Jan 2020 8:33AM $0.115 $0.027 fallen by 76.52%
- Ceasing to be a substantial holder 20 Dec 2019 4:57PM $0.150 $0.027 fallen by 82%
- Pharmaxis Business Plan Update 18 Dec 2019 8:37AM $0.260 $0.027 fallen by 89.62%
- Boehringer discontinues development of BI 1467335 for NASH 18 Dec 2019 8:36AM $0.260 $0.027 fallen by 89.62%
- Investor Conference Call 17 Dec 2019 4:41PM $0.260 $0.027 fallen by 89.62%
- Trading Halt 16 Dec 2019 9:22AM $0.260 $0.027 fallen by 89.62%
- Investor Presentation 25 Nov 2019 8:24AM $0.225 $0.027 fallen by 88%
- Change of Director's Interest Notice 21 Nov 2019 4:25PM $0.235 $0.027 fallen by 88.51%
- Appendix 3B - Issue of Employee Options 21 Nov 2019 4:21PM $0.235 $0.027 fallen by 88.51%
- Results of Meeting 21 Nov 2019 4:17PM $0.235 $0.027 fallen by 88.51%
- CEO Presentation to 2019 AGM 21 Nov 2019 1:39PM $0.220 $0.027 fallen by 87.73%
- Chairman's Address to Shareholders 21 Nov 2019 1:27PM $0.220 $0.027 fallen by 87.73%
- Appendix 3B - Grant of Employee Options 6 Nov 2019 4:20PM $0.190 $0.027 fallen by 85.79%
- Appendix 4C - quarterly 31 Oct 2019 8:24AM $0.195 $0.027 fallen by 86.15%
- Quarterly Shareholder Update - September 2019 31 Oct 2019 8:23AM $0.195 $0.027 fallen by 86.15%
- Pharmaxis Science Update - Anti-Fibrotic Pipeline 30 Oct 2019 8:16AM $0.200 $0.027 fallen by 86.50%
- CEO Presentation to 2019 AusBiotech Conference 30 Oct 2019 8:16AM $0.200 $0.027 fallen by 86.50%
- FDA Provides Guidance on Bronchitol Approval Steps 28 Oct 2019 9:20AM $0.200 $0.027 fallen by 86.50%
- Pharmaxis Cancer Drug Progressing in Clinic 24 Oct 2019 8:26AM $0.210 $0.027 fallen by 87.14%

326 - 350 of 836 results

Page 14 of 34

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.